A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

NCT01594970 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: Bimatoprost 0.01%

Sponsor

Allergan